Search icon

Optimer Pharmaceuticals, Inc.

Optimer Pharmaceuticals is a Business Corporation registed in Alaska. Founded in April 2011, with the entity number 134748, its principal address is 4755 NEKUS CENTER DRIVE, SAN DIEGO, CA 92121. The entity did not apply for any business licenses yet. Currently in Withdrawn. Optimer Pharmaceuticals has 21 key officers and 8 shareholders.

Company Details

Legal Name: Optimer Pharmaceuticals, Inc.
Entity Type: Business Corporation

Optimer Pharmaceuticals, Inc. is structured as a Business Corporation, a common type of corporate entity designed to conduct a wide range of business activities. In Alaska, a Business Corporation (often referred to as a "C-Corp") is a separate legal entity from its owners (shareholders), offering them limited liability protection and enabling the company to raise capital through the issuance of stock.
In Alaska, Business Corporations are governed by Title 10, Chapter 06 – Alaska Corporations Code.

Status: Withdrawn

"Withdrawn" status typically means that Optimer Pharmaceuticals, Inc., which was originally qualified or registered to do business in Alaska as a foreign entity (a company formed outside Alaska), has voluntarily withdrawn its registration or authorization to do business in Alaska, meaning it has ceased its operations in the state and is no longer recognized as an active entity there.

AK Formed Date: 22 Apr 2011 (14 years ago)
Duration: Perpetual
Entity Number: 134748

The entity number, 134748, is a unique identifier assigned by the Alaska Department of Commerce, Community, and Economic Development to Optimer Pharmaceuticals, Inc.. This number can be used to verify the company's registration and access official records.

Home State: DELAWARE
Entity Mailing Address: 65 HAYDEN AVE, LEXINGTON, MA 02421
Entity Physical Address: 4755 NEKUS CENTER DRIVE, SAN DIEGO, CA 92121

Key Officers & Management

Name Role Shares
Alger Fred Management Previous Shareholder 16.14
Bellevue Asset Management Previous Shareholder 5.24
Bhooshi De Silva Previous Vice President -
Blackroch, Inc. Previous Shareholder 6.80
C T Corporation System Previous Registered Agent -
Cubist Pharmaceuticals, Inc. Shareholder 100.00
Fidelity Management and Research Previous Shareholder 11.30
Hemal Shah Previous Vice President -
John D Prunty Previous Vice President -
Linda Amper Previous Vice President -

Date of last update: 14 Feb 2025

Sources: State of Alaska - Department of Commerce, Community, and Economic Development